Up-regulation of functional voltage-dependent sodium channels by insulin in cultured bovine adrenal chromaffin cells

J Neurochem. 1996 Oct;67(4):1401-8. doi: 10.1046/j.1471-4159.1996.67041401.x.

Abstract

Treatment of cultured bovine adrenal chromaffin cells with 100 nM insulin raised [3H]saxitoxin ([3H]-STX) binding in a time-dependent manner (t1/2 = 26 h). Insulin (100 nM for 4 days) increased the Bmax of [3H]STX binding by 49% without changing the KD value and also augmented the maximal influx of 22Na+ due to 560 microM veratridine by 39% without altering the EC50 value of veratridine. The stimulatory effect of insulin on 22Na+ influx was concentration-dependent with an EC50 of 3 nM, whereas insulin-like growth factor (IGF)-I had little effect at 1 nM. Ptychodiscus brevis toxin-3 allosterically potentiated veratridine (100 microM)-induced 22Na+ influx by approximately twofold in both insulin-treated cells and untreated cells. Veratridine-induced 45Ca2+ influx via voltage-dependent Ca2+ channels and catecholamine secretion were also enhanced by insulin treatment, whereas insulin did not alter nicotine-induced 22Na+ influx via the nicotinic receptor-ion channel complex and high-K+ (direct activation of voltage-dependent Ca2+ channels)-induced 45Ca2+ influx. Stimulatory effects of insulin on [3H]-STX binding and veratridine-induced 22Na+ influx were nullified by simultaneous treatment with either 5,6-dichlorobenzimidazole riboside, an inhibitor of RNA synthesis, or cycloheximide, an inhibitor of protein synthesis, whereas insulin treatment did not appreciably increase the level of mRNA encoding the Na+ channel alpha-subunit. These results suggest that the binding of insulin to insulin (but not IGF-I) receptors mediates the up-regulation of functional Na+ channel expression at plasma membranes; this up-regulation may be due, at least in part, to the de novo synthesis of an as yet unidentified protein(s).

MeSH terms

  • Adrenal Medulla / metabolism*
  • Animals
  • Cattle
  • Cells, Cultured
  • Chromaffin Cells / drug effects
  • Chromaffin Cells / metabolism*
  • Cycloheximide / pharmacology
  • Dichlororibofuranosylbenzimidazole / pharmacology
  • Dinoflagellida
  • Drug Synergism
  • Electrophysiology
  • Epinephrine / metabolism
  • Insulin / pharmacology*
  • Insulin-Like Growth Factor I / pharmacology
  • Kinetics
  • Marine Toxins / pharmacology
  • Norepinephrine / metabolism
  • Ouabain / pharmacology
  • Oxocins*
  • Receptor, Insulin / physiology
  • Receptors, Nicotinic / drug effects
  • Receptors, Nicotinic / physiology
  • Saxitoxin / metabolism
  • Sodium / metabolism
  • Sodium Channels / biosynthesis*
  • Sodium Channels / physiology
  • Transcription, Genetic / drug effects*
  • Up-Regulation
  • Veratridine / pharmacology

Substances

  • Insulin
  • Marine Toxins
  • Oxocins
  • Receptors, Nicotinic
  • Sodium Channels
  • Saxitoxin
  • Dichlororibofuranosylbenzimidazole
  • Ouabain
  • Insulin-Like Growth Factor I
  • Veratridine
  • brevetoxin T17
  • Cycloheximide
  • Sodium
  • Receptor, Insulin
  • Norepinephrine
  • Epinephrine